News Archive

August 6, 2026

FDA approves Replimune melanoma drug previously rejected twice

  • Portfolio Company News
Read more
July 29, 2026

Less than year after launch, Caldera lines up $278M financing and Nasdaq debut

  • Portfolio Company News
Read more
June 30, 2026

Two Roads Diverged

  • From the Trenches
Read more
June 25, 2026

Remix Therapeutics secures $100M and a reverse merger

  • Portfolio Company News
Read more
June 24, 2026

Novartis targets undruggable cancers with $1.9bn Antares Therapeutics deal

  • Portfolio Company News
Read more